Celldex Therapeutics Stock Widgets and Gadgets
CLDX Stock | USD 38.85 0.87 2.29% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- CLDX Celldex Therapeutics
- Latest Celldex completes patient enrollment for Phase 2 urticaria trial
- CLDX 38.85 0.87
- Low 37.99
- High 39.41
- Volume 552.5 K
- Alpha -0.0683
- Beta 1.01
- Return On Equity -0.37
- Return On Asset -0.22
- Operating Margin (8.50) %
- Current Valuation 1.7 B
- Shares Outstanding 65.7 M
- Shares Owned By Insiders 0.34 %
- Shares Owned By Institutions 96.78 %
- Number Of Shares Shorted 6.56 M
- Price To Earning (2.21) X
- Price To Book 6.01 X
- Price To Sales 374.64 X
- Revenue 6.88 M
- Gross Profit (79.9 M)
- EBITDA (139.03 M)
- Net Income (141.43 M)
- Cash And Equivalents 356.82 M
- Cash Per Share 7.63 X
- Total Debt 2.54 M
- Debt To Equity 0.01 %
- Current Ratio 12.29 X
- Book Value Per Share 7.68 X
- Cash Flow From Operations (107.29 M)
- Short Ratio 5.50 X
- Earnings Per Share (2.92) X
- Target Price 70.71
- Number Of Employees 160
- Beta 1.56
- Market Capitalization 2.5 B
- Total Asset 465.63 M
- Retained Earnings (1.4 B)
- Working Capital 400.57 M
- Current Asset 294.94 M
- Current Liabilities 30.24 M
- Net Asset 465.63 M
- Accumulation Distribution 19905.76
- Daily Balance Of Power 0.6127
- Rate Of Daily Change 1.02
- Day Median Price 38.7
- Day Typical Price 38.75
- Price Action Indicator 0.59
- Period Momentum Indicator 0.87
Market Snapshot Widget Example
DAX Index Germany | 17,861 0.70 | |
Taiwan Weighted Taiwan | 19,411 0.59 | |
PSI 20 Stock Portugal | 6,515 3.50 | |
CROBEX Croatia | 2,803 0.14 | |
Budapest SE Hungary | 65,126 0.12 | |
IDX 30 Jakarta Indonesia | 467.48 0.14 | |
ISEQ 20 Price Ireland | 1,646 0.05 | |
NYSE Comp USA | 17,602 0.82 | |
Tel Aviv 35 Israel | 1,912 1.29 | |
Coreshares Index Tracker South Afric | 1,026 0.59 | |
IPC MEXICO Mexico | 56,552 1.23 | |
KL Technology Malaysia | 62.69 0.14 | |
IBEX 35 Index Spain | 10,890 1.50 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,554 0.49 | |
SPASX Dividend Opportunities Australia | 1,655 0.68 | |
HNX 30 Vietnam | 481.21 2.96 | |
Bucharest BET-NG Romania | 1,205 0.11 | |
AMS Small Cap Netherlands | 1,189 0.52 | |
Oslo Exchange Mutual Norway | 1,290 0.01 | |
BEL Small Belgium | 9,020 1.28 | |
RTSI Index Russia | 1,173 0.06 | |
Basic Materials Brazil | 5,966 0.05 | |
Swiss Leader Price Switzerland | 1,847 0.38 | |
Fondo Mutuo ETF Chile | 1,407 0.21 | |
Athens General Comp Greece | 1,420 1.99 | |
Stock Exchange Of Thailand | 1,350 1.31 | |
PX Prague Stock Czech Repub | 1,551 0.02 | |
THE PHILIPPINE STOCK Philippines | 6,444 0.02 | |
WIG 30 Poland | 3,102 1.72 | |
BIST Electricity Turkey | 595.36 0.54 |
Investing Ideas
In addition to having Celldex Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Celldex Therapeutics
Compare Celldex Therapeutics To Peers
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celldex Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Celldex Stock please use our How to Invest in Celldex Therapeutics guide.Note that the Celldex Therapeutics information on this page should be used as a complementary analysis to other Celldex Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Celldex Stock analysis
When running Celldex Therapeutics' price analysis, check to measure Celldex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celldex Therapeutics is operating at the current time. Most of Celldex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Celldex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celldex Therapeutics' price. Additionally, you may evaluate how the addition of Celldex Therapeutics to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is Celldex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Celldex Therapeutics. If investors know Celldex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Celldex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.92) | Revenue Per Share 0.142 | Quarterly Revenue Growth 1.561 | Return On Assets (0.22) | Return On Equity (0.37) |
The market value of Celldex Therapeutics is measured differently than its book value, which is the value of Celldex that is recorded on the company's balance sheet. Investors also form their own opinion of Celldex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Celldex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Celldex Therapeutics' market value can be influenced by many factors that don't directly affect Celldex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Celldex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Celldex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Celldex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.